Evans, Charles E <br/><br/>
ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease.  [electronic resource] 

 -  Acta neuropathologica  03 2020 
 - 485-502 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-0533 
<br/><br/><label>Standard No.: </label>10.1007/s00401-019-02098-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--metabolism<br/>Amyloidogenic Proteins--metabolism<br/>Angiotensin-Converting Enzyme 2--metabolism<br/>Animals<br/>Cognitive Dysfunction--metabolism<br/>Diminazene--analogs & derivatives<br/>Disease Models, Animal<br/>Mice<br/>Mice, Transgenic<br/>Proto-Oncogene Mas